Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

M. R. Smith, F. Hong, H. Li, L. I. Gordon, R. D. Gascoyne, E. M. Paietta, R. H. Advani, A. Forero-Torres, S. J. Horning, B. S. Kahl

Research output: Contribution to journalLetterpeer-review

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)517-519
Number of pages3
Issue number2
StatePublished - Feb 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this